Regulatory effect of SOCS on NF-κB activity in murine monocytes/macrophages

DNA and Cell Biology

Volumn 22, Issue 2, 2003, Pages 131-139

  Park, Sun Hee ^a   Kim, Kyoung Eun ^a   Hwang, Ha Young ^a   Kim, Tae Yoon ^a,b,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE ACTIVITY; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CARRIER PROTEINS; CELL LINE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MONOCYTES; MUTATION; NF-KAPPA B; PHAGOCYTES; PROMOTER REGIONS (GENETICS); PROTEINS; REPRESSOR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 0037307634     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903321515931     Document Type: Article

References (37)

1. ADAMS, T.E., HANSEN, J.A., STARR, R., NICOLA, N.A., HILTON, D.J., and BILLESTRUP, N. (1998). Growth hormone preferentially induces the rapid, transient expression of SOCS3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273, 1285-1287.
2. ALEXANDER, W.S., STARR, R., FENNER, J.E., SCOTT, C.L., HANDMAN, E., SPRIGG, N.S., CORBIN, J.E., CORNISH, A.L., DARWICHE, R., OWKCZAREK, C.M., et al. (1999). SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597-608.
3. BALDWIN, A.S., JR. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14, 649-693.
4. BJORBAEK, C., ELMQUIST, J.K., FRANTZ, J.D., SHOELSON, S.E., and FILER, J.S. (1998). Identification of SOCS3 as a potential mediator of central leptin resistance. Mol. Cell 1, 619-625.
5. BRENDER, C., NIELSON, M., KALTOFT, K., MIKKELSON, G., ZHANG, Q., WASIK, M., BILLESTRUP, N., and ØDUM, N. (2001). STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Blood 97, 1056-1062.
6. CACALANO, N.A., SANDEDN, D., and JOHNSTON, J.A. (2001). Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3, 460-465.
7. CASSATELLA, M.A., GASPERANI, S., BOVOLENTA, C., CALZETTI, F., VOLLEBREGT, M., SCAPINI, P., MARCHI, M., SUZUKI, R., SUZUKI, A., and YOSHIMURA, A. (1999). Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94, 2880-2889.
8. COHNEY, S.J., SANDEN, D., CACALONA, N.A., YOSHIMURA, A., MUI, A., MIGONE, T.S., and JOHNSTON, J.A. (1999). SOCS3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell Biol. 19, 4980-4988.
9. CHEN, X.P., LOSMAN, J.A., and ROTHMAN, P. (2000). SOCS proteins, regulators of intracellular signaling. Immunity 13, 287-290.
10. ENDO, T.A., MASUHARA, M., YOKOUCHI, M., SUZUKI, R., SAKAMOTO, H., MITSUI, K., MATSUMOTO, A., TANIMURA, S., OHTSUBO, M., MISAWA, H., et al. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924.
11. GHOSH, S., MAY, M.J., and KOPP, E.B. (1998). NF-kappa B and Rel proteins: Evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
12. HILTON, D.J., RICHARDSON, R.T., ALEXANDER, W.S., VINEY, E.M., WILLSON, T.A., SPRIGG, N., STARR, R., NICHOLSON, S.E., METCALF, D., and NICOLA, N.A. (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114-119.
13. ITO, S., ANSARI, P., SAKATSUME, M., DICKENSHEETS, H., VASQUEZ, N., DONELLY, R.P., LARNER, A.C., and FINBLOOM, D.S. (1999). Interleukin-10 inhibits expression of both interferon-α- and interferon-γ-induced genes by suppressing tyrosine phosphorylation of Stat1. Blood 93, 1456-1463.
14. KAMURA, T., SATO, S., HAQUE, D., LIU, L., KAELIN, W.G., JR., CONAWAY, R.C., and CONAWAY, J.C. (1998). The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat and ankyrin repeat families. Genes Dev 12, 3872-3881.
15. KIM, K.-E., GU, C., THAKUR, S., VIEIRA, E., LIN, J.C., and RABSON, A.B. (2000). Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 proto-oncogenes. Oncogene 19, 1334-1345.
16. MARINE, J.C., MCKAY, C., WANG, D., TOPHAM, D.J., PARGANAS, E., NAKAJIMA, H., PENDEVILLE, H., YASUKAWA, H., SASAKI, A., YOSHIMURA, A., et al. (1999). SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98, 617-627.
17. METCALF, D. (1999). The SOCS-1 story. Exp. Hematol. 27, 1715-1723.
18. METCALF, D., DI RAGO, L., MIFSUD, S., HARTLEY, L., and ALEXANDER, W.S. (2000a). The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-γ and lacking the SOCS-1 gene. Proc. Natl. Acad. Sci. USA 97, 9174-9179.
19. METCALF, D., GREENHALGH, C.J., VINEY, E., WILLSON, T.A., STARR, R., NICOLA, N.A., HILTON, D.J., and ALEXANDER, W.S. (2000b). Gigantism in mice lacking suppressor of cytokine signaling-2. Nature 40, 1069-1072.
20. NAKA, T., MATSUMOTO, T., NARAZAKI, M., FUJIMOTO, M., MORITA, Y., OHSAWA, Y., SAITO, H., NAGASAWA, T., UCHIYAMA, Y., and KISHIMOTO, T. (1998). Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577-15582.
21. NAKA, T., NARAZAKI, M., HIRATA, M., MATSUMOTO, T., MINAMOTO, S., AONO, A., NISHIMOTO, N., KAJITA, T., TAGA, T., YOSHIZAKI, K., et al. (1997). Structure and function of new STAT-induced STAT inhibitor. Nature 387, 924-929.
22. NICHOLSON, S.E., WILLSON, T.A., FARLEY, A., STARR, R., ZHANG, J.G., BACA, M., ALEXANDER, W.S., METCALF, D., HILTON, D.J., and NICOLA, N.A. (1999). Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18, 375-385.
23. OHOTTIGER, M., FELZIEN, L.K., and NABEL, G.J. (1998). Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J. 17, 3124-3134.
24. OHYA, K., KAJIGAYA, S., YAMASHITA, Y., MIYAZATO, A., HATAKE, K., MIURA, Y., IKEDA, U., SHIMADA, K., OZAWA, K., and MANO, H. (1997). SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J. Biol. Chem. 272, 27178-27182.
25. ROMANO, M.F., LAMBERTI, A., PETRELLA, A., BISOGNI, R., TASSONE, P.F., FORMISANO, S., VENUTA, S., and TURCO, M.C. (1996). IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J. Immunol. 156, 2119-2123.
26. SCHMITZ, J., WEISSENBACH, M., HAAN, S., HEINRICH, P.C., and SCHAPER, F. (2000). SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 275, 12848-12856.
27. SCHOTTELIUS, A.J., MAYO, M.W., BALFIYR SARTOR, R., and BALDWIN, A.S. (1999). Interleukin-10 signaling blocks inhibitor of IκB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 274, 31868-31874.
28. SHIMIZU, H., MITOMO, K., WATANABE, T., OKAMOTO, S., and YAMAMOTO, K. (1990). Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell Biol. 10, 561-568.
29. SONG, MM., and SHUAI, K. (1998). The suppressor of cytokine signaling (SOCS) 1 and SOCS 3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273, 35056-35062.
30. SONG, S., LING-HU, H., ROEBUCK, K.A., RABBI, M.F., DONNELLY, R.P., and FINNEGAN, A. (1997). Interelukin-10 inhibits interferon-γ-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood 89, 4461-4469.
31. STARR, R., WILLSON, T.A., VINEY, E.M., MURRAY, L.J., RAYNER, J.R., JENKINS, B.J., GONDA, T.J., ALEXANDER, W.S., METCALF, D., NICOLA, N.A. et al. (1997). A family of cytokine-inducible inhibitors of signaling. Nature 387, 917-921.
32. STOIBER, D., KOVARIK, P., COHNEY, S., JOHNSTON, J.A., STEINLEIN, P., and DECKER, T. (1999). Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol. 163, 2640-2647.
33. THAKUR, S., LIN, H.C., TSENG, W.T., KUMAR, S., BRAVO, R., FOSS, F., GÉLINAS, C, and RABSON, A.B. (1994). Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9, 2335-2344.
34. WANG, P., WU, P., SIEGEL, M.I., EGAN, R.W., and MOTASIM BILLAH, M. (1995). Interleukin-10 (IL-10) inhibits nuclear factor κB (NF-κB) activation in human monocytes. J. Biol. Chem. 270, 9558-9563.
35. YANG, C.H., MURTI, A., PFEFFER, S.R., BASU, L., KIM, J.G., and PFEFFER, L.M. (2000). IFNα/β promotes cell survival by activating NF-κB. Proc. Natl. Acad. Sci. USA 97, 13631-13636.
36. YOU, M., FLICK, L.M., YU, D., and FENG, G.S. (2001). Modulation of the nuclear factor κB pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J. Exp. Med. 193, 101-109.
37. ZHANG, J.G., FARELY, A., NICHOLSON, S.E., WILLSON, T.A., ZUGARA, L.M., SIMPSONS, R.J., MORITZ, R.L., CARY, D., RICHARDSON, R., HAUSMANN, G., et al. (1999). The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071-2076.